The unfortunate reality is cancer touches almost everyone at some point in their lives, whether it's yourself or a loved one. But each person has a unique story, especially when it comes to cancer treatment. We believe if faced with a cancer diagnosis, you need solutions that help you face the financial, physical and emotional challenges often experienced by cancer patients and their families - before, during, and after treatment.
The unfortunate reality is cancer touches almost everyone at some point in their lives, whether it's yourself or a loved one. But each person has a unique story, especially when it comes to cancer treatment. We believe if faced with a cancer diagnosis, you need solutions that help you face the financial, physical and emotional challenges often experienced by cancer patients and their families - before, during, and after treatment.
You never know what the future could hold, which is why it’s so important to help protect yourself with Aflac Cancer Protection Assurance. These plans don’t just help with medical expenses. Rather, they pay you cash directly, unless assigned—instead of a doctor or hospital—to help you manage expenses like bills, rent, car payments, groceries, child care and more. Cancer is expensive, but with Aflac Cancer Protection Assurance, patients can focus on the most important thing: getting better.
Click to view important policy limitations and exclusions.
Collapse to close important benefit scenario details.
Aflac Cancer Protection Assurance – Option 1 The above example is based on a scenario for Aflac Cancer Protection Assurance - Option 1 with three units of the Initial Diagnosis Building Benefit Rider (purchased three years prior to claim) and includes the following benefit conditions: Initial Diagnosis Benefit of $1,250, Initial Diagnosis Building Benefit Rider (three units for three years) of $900, Bone Marrow Biopsy (Cancer Screening Benefit) of $25, IV Chemotherapy for 3 months (Physician-Administered Radiation Therapy, Chemotherapy, Immunotherapy, or Experimental Chemotherapy Benefit) of $2,400, Immunotherapy (Physician-Administered Radiation Therapy, Chemotherapy, Immunotherapy, or Experimental Chemotherapy Benefit) for 6 months of $4,800, Antinausea Benefit (9 months) of $450, Stem Cell Transplant Benefit of $3,500, Hospital Confinement Benefit (4 days) of $400, Annual Care Benefit (paid on the first anniversary of diagnosis) of $250.
Aflac Cancer Protection Assurance – Option 2 The above example is based on a scenario for Aflac Cancer Protection Assurance - Option 2 with three units of the Initial Diagnosis Building Benefit Rider (purchased three years prior to claim) and includes the following benefit conditions: Initial Diagnosis Benefit of $5,000, Initial Diagnosis Building Benefit Rider (three units for three years) of $900, Bone Marrow Biopsy (Cancer Screening Benefit) of $75, IV Chemotherapy for 3 months (Physician-Administered Radiation Therapy, Chemotherapy, Immunotherapy, or Experimental Chemotherapy Benefit) of $4,800, Immunotherapy (Physician-Administered Radiation Therapy, Chemotherapy, Immunotherapy, or Experimental Chemotherapy Benefit) for 6 months of $9,600, Antinausea Benefit (9 months) of $900, Stem Cell Transplant Benefit of $7,000, Hospital Confinement Benefit (4 days) of $800, Annual Care Benefit (paid on the first anniversary of diagnosis) of $500.
Aflac Cancer Protection Assurance – Option 3 The above example is based on a scenario for Aflac Cancer Protection Assurance - Option 3 with three units of the Initial Diagnosis Building Benefit Rider (purchased three years prior to claim) and includes the following benefit conditions: Initial Diagnosis Benefit of $7,500, Initial Diagnosis Building Benefit Rider (three units for three years) of $900, Bone Marrow Biopsy (Cancer Screening Benefit) of $100, IV Chemotherapy for 3 months (Physician-Administered Radiation Therapy, Chemotherapy, Immunotherapy, or Experimental Chemotherapy Benefit) of $6,000, Immunotherapy (Physician-Administered Radiation Therapy, Chemotherapy, Immunotherapy, or Experimental Chemotherapy Benefit) for 6 months of $12,000, Antinausea Benefit (9 months) of $1,350, Stem Cell Transplant Benefit of $10,000, Hospital Confinement Benefit (4 days) of $1,200, Annual Care Benefit (paid on the first anniversary of diagnosis) of $750.
Benefits and/or premiums may vary based on state and benefit option selected. Riders are available for an additional cost. The policy/riders have limitations, exclusions, and pre-existing condition limitations that may affect benefits payable. The policy and certain riders contain a 30-day waiting period. This brochure is for illustrative purposes only. Refer to the policy/riders for complete benefit details, definitions, limitations and exclusions.
Expand to view important benefit scenario details.
Aflac Cancer Protection Assurance – Option 1 The above example is based on a scenario for Aflac Cancer Protection Assurance - Option 1 with three units of the Initial Diagnosis Building Benefit Rider (purchased three years prior to claim) and includes the following benefit conditions: Initial Diagnosis Benefit of $1,250, Initial Diagnosis Building Benefit Rider (three units for three years) of $900, Bone Marrow Biopsy (Cancer Screening Benefit) of $25, IV Chemotherapy for 3 months (Physician-Administered Radiation Therapy, Chemotherapy, Immunotherapy, or Experimental Chemotherapy Benefit) of $2,400, Immunotherapy (Physician-Administered Radiation Therapy, Chemotherapy, Immunotherapy, or Experimental Chemotherapy Benefit) for 6 months of $4,800, Antinausea Benefit (9 months) of $450, Stem Cell Transplant Benefit of $3,500, Hospital Confinement Benefit (4 days) of $400, Annual Care Benefit (paid on the first anniversary of diagnosis) of $250.
Aflac Cancer Protection Assurance – Option 2 The above example is based on a scenario for Aflac Cancer Protection Assurance - Option 2 with three units of the Initial Diagnosis Building Benefit Rider (purchased three years prior to claim) and includes the following benefit conditions: Initial Diagnosis Benefit of $5,000, Initial Diagnosis Building Benefit Rider (three units for three years) of $900, Bone Marrow Biopsy (Cancer Screening Benefit) of $75, IV Chemotherapy for 3 months (Physician-Administered Radiation Therapy, Chemotherapy, Immunotherapy, or Experimental Chemotherapy Benefit) of $4,800, Immunotherapy (Physician-Administered Radiation Therapy, Chemotherapy, Immunotherapy, or Experimental Chemotherapy Benefit) for 6 months of $9,600, Antinausea Benefit (9 months) of $900, Stem Cell Transplant Benefit of $7,000, Hospital Confinement Benefit (4 days) of $800, Annual Care Benefit (paid on the first anniversary of diagnosis) of $500.
Aflac Cancer Protection Assurance – Option 3 The above example is based on a scenario for Aflac Cancer Protection Assurance - Option 3 with three units of the Initial Diagnosis Building Benefit Rider (purchased three years prior to claim) and includes the following benefit conditions: Initial Diagnosis Benefit of $7,500, Initial Diagnosis Building Benefit Rider (three units for three years) of $900, Bone Marrow Biopsy (Cancer Screening Benefit) of $100, IV Chemotherapy for 3 months (Physician-Administered Radiation Therapy, Chemotherapy, Immunotherapy, or Experimental Chemotherapy Benefit) of $6,000, Immunotherapy (Physician-Administered Radiation Therapy, Chemotherapy, Immunotherapy, or Experimental Chemotherapy Benefit) for 6 months of $12,000, Antinausea Benefit (9 months) of $1,350, Stem Cell Transplant Benefit of $10,000, Hospital Confinement Benefit (4 days) of $1,200, Annual Care Benefit (paid on the first anniversary of diagnosis) of $750.
Benefits and/or premiums may vary based on state and benefit option selected. Riders are available for an additional cost. The policy/riders have limitations, exclusions, and pre-existing condition limitations that may affect benefits payable. The policy and certain riders contain a 30-day waiting period. This brochure is for illustrative purposes only. Refer to the policy/riders for complete benefit details, definitions, limitations and exclusions.
Collapse to close important benefit scenario details.